AMD vs NOW: Which Is the Better Buy?

Side-by-side comparison of Advanced Micro Devices, Inc. and ServiceNow, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-24.
Advanced Micro Devices, Inc. Β· Technology
$614.61
-13.7% upside to fair value
Med Conviction Grade C
VS
ServiceNow, Inc. Β· Technology
$139.82
+16.2% upside to fair value
Med Conviction Grade A- High Quality
QuantHub Verdict
NOW has more upside to fair value (+16.2%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric AMD NOW
Current Price $614.61 $139.82
Fair Value Estimate $530.25 $162.50
Upside to Fair Value -13.7% +16.2%
Market Cap $1,002.2B $144.6B
Forward P/E β€” β€”
EV / EBITDA 93.4x 43.1x
Price / Sales 24.3x 9.8x
Price / FCF 119.3x 31.5x
Revenue Growth YoY +50.1% +24.0%
Gross Margin 53.2% 74.8%
Operating Margin 15.7% 11.4%
Return on Equity 10.1% 13.8%
Dividend Yield 0% 0%
FCF Yield 0.84% 3.17%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
AMD β€” Advanced Micro Devices, Inc.
Advanced Micro Devices designs x86 CPUs, GPUs, and data-center accelerators across two segments, Computing and Graphics and Enterprise, Embedded and Semi-Custom, with 31,000 employees and a $1.002 trillion market capitalization at $614.61 per share. The business quality is genuinely improving: revenue grew 50.1% year over year in the most recent quarter, earnings grew 163.4% year over year in the…
NOW β€” ServiceNow, Inc.
ServiceNow provides a cloud-based enterprise workflow platform spanning IT service management, operations, employee workflows, CRM, AI orchestration and security. Business quality is high because its common data model, deeply embedded workflows and cross-department deployments create meaningful switching costs, while roughly 90% of the Fortune 500 use the platform and more than 85 billion workflo…
Accumulation Zones
Metric AMD NOW
Zone Low $397.69 $121.88
Zone High $450.71 $138.12
In Buy Zone? No No
← AMD Research    NOW Research β†’    All Research